View Post

New compounds offer a two-for-one punch to fight estrogen-sensitive breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Scripps Research Institute From: news-medical.net A set of compounds developed by scientists at Scripps Research in Florida target estrogen-sensitive breast cancer cells in new ways, potentially creating better options for patients with treatment-resistant cancers. “Hormone therapies for breast cancer have been one of the greatest success stories of molecularly targeted medicines. But a significant fraction of patients don’t respond …

View Post

Does Letrozole Cause Weight Gain?

In In The News by Barbara Jacoby

By: Laura Carfang, Ed.D. Executive Director and Founder From: Survivingbreastcancer.org Weight gain is one of the many potential side effects of Letrozole, an Aromatase Inhibitor. In fact, “will Letrozole make me gain weight?” is one of the most common questions we hear in our support groups. Not every person taking Letrozole gains weight. Everyone responds differently to these endocrine therapies. …

View Post

Breast cancer can form ‘sleeper cells’ after drug treatment

In In The News by Barbara Jacoby

Source: Imperial College London From: sciencedaily.com Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment. These are the early-stage findings from scientists at Imperial College London, who studied human breast cancer cells in the laboratory. The team, who studied a group of breast cancer drugs called …